Interview: IHL-42X showing tangible benefits for patients but market yet to reflect Incannex’s pipeline progress, says CEO Joel Latham
Incannex Healthcare, the Melbourne-based clinical-stage biopharmaceutical company developing therapies for the treatment of obstructive sleep apnea, rheumatoid arthritis and generalized anxiety disorder,